NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Olga Kondrashova
QIMR Berghofer Medical Research Institute - Herston / Australia
Others
AD Scientific Index ID: 4461792
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Olga Kondrashova's MOST POPULAR ARTICLES
1-)
Deep learning in cancer diagnosis, prognosis and treatment selectionKA Tran, O Kondrashova, A Bradley, ED Williams, JV Pearson, N WaddellGenome Medicine 13, 1-17, 20213642021
2-)
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian …O Kondrashova, M Nguyen, K Shield-Artin, AV Tinker, NNH Teng, ...Cancer discovery 7 (9), 984-998, 20173572017
3-)
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinomaO Kondrashova, M Topp, K Nesic, E Lieschke, GY Ho, MI Harrell, ...Nature communications 9 (1), 3970, 20182002018
4-)
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancerE Sanij, KM Hannan, J Xuan, S Yan, JE Ahern, AS Trigos, N Brajanovski, ...Nature communications 11 (1), 2641, 20201222020
5-)
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian CarcinomaK Nesic, O Kondrashova, RM Hurley, CD McGehee, CJ Vandenberg, ...Cancer Research 81 (18), 4709-4722, 2021592021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept